Amyotrophic lateral sclerosis (ALS) is a fatal neurodegenerative disease with few treatment options. Since 2018, the Sean M.
6don MSN
A team of researchers from the Sant Pau Research Institute (IR Sant Pau) has published a study in the Journal of ...
News Medical on MSN1d
First insights into genotype and phenotype of familial amyotrophic lateral sclerosis in Egypt: early onset and high consanguinityAmyotrophic lateral sclerosis (ALS) is a devastating neurodegenerative disease characterized by the progressive degeneration of motor neurons, ...
Medpage Today on MSN2d
Two Investigational Treatments for ALS Show Glimmer of HopeThe first four treatments in a platform trial for amyotrophic lateral sclerosis (ALS) failed to reach key endpoints in phase ...
Down syndrome, or trisomy 21, is caused by the presence of a third copy of the 21st chromosome. Affected individuals have ...
NEW YORK, NY / ACCESS Newswire / February 19, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of Voyager ...
News Medical on MSN2d
Groundbreaking ALS platform trial accelerates research and drug testingAmyotrophic lateral sclerosis (ALS) is a fatal neurodegenerative disease with few treatment options. Since 2018, the Sean M. Healey & AMG Center for ALS at Massachusetts General Hospital (MGH), a ...
ALS is a progressive neurodegenerative disease that currently has no cure. Commonly known as Lou Gehrig’s disease, ALS ...
Scientists have developed a lipid nanoparticle system capable of delivering messenger RNA (mRNA) to the brain via intravenous injection, a challenge that has long been limited by the protective nature ...
Oxysterols are a class of molecules derived from cholesterol via oxidation or as byproducts of cholesterol synthesis. Despite their relatively low ...
Amylyx Pharmaceuticals (NASDAQ:AMLX – Get Free Report) is expected to be releasing its earnings data before the market opens ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback